Welcome to our dedicated page for Ziff Davis news (Ticker: $ZD), a resource for investors and traders seeking the latest updates and insights on Ziff Davis stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Ziff Davis's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Ziff Davis's position in the market.
Ziff Davis, Inc. (NASDAQ: ZD) reported strong financial results for Q1 2024, with revenue and income growth. Quarterly revenues increased by 2.4%, income from operations rose by 36.3%, and adjusted net income grew by 13.0%. The Company ended the quarter with $891.1 million in cash, cash equivalents, and investments. Ziff Davis reaffirmed its 2024 guidance, expecting revenue between $1.411 billion and $1.471 billion, adjusted EBITDA between $500 million and $521 million, and adjusted diluted EPS between $6.43 and $6.77.
Castle Connolly released the Castle Connolly 2024 Top Asian American and Pacific Islander Doctors list, recognizing 722 leading AAPI doctors across 38 states and 73 specialties. The list doubled from the previous year, part of Castle Connolly's DEI initiative to honor top clinicians with shared backgrounds. AAPI population faces health inequities due to language and cultural barriers, with Castle Connolly's Top AAPI Doctors providing culturally sensitive healthcare.
